approaches to treating elderly patients with all: the role of tkis and antibody therapies
Published 1 year ago • 25 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:20
the evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with all
-
1:31
how the treatment and management of all changes with age
-
2:14
challenges in the management of older all patients
-
3:25
treatment approaches for elderly/unfit patients with aml ineligible for intensive chemotherapy
-
2:04
the importance of individualizing treatment approaches in hl to improve patient outcomes
-
3:28
inotuzumab as a potential treatment for elderly patients with all
-
0:33
the management of elderly patients with cll
-
2:55
recent advances in the treatment of ph all and the important role of tkis
-
5:10
why do our bodies age? - monica menesini
-
2:06
living with trisomy 12p (communication without words)
-
6:56
prognostic factors in acute lymphoblastic leukemia
-
1:37
the importance of improving treatment-free remission in patients with cml
-
2:33
improving outcomes in elderly patients with cancer
-
0:56
long-term overall survival of aya patients with all who complete therapy on dfci consortium trials
-
1:38
future treatment strategies for r/r ph all
-
2:02
important prognostic factors to evaluate in cll patients in the era of small molecules
-
5:16
how the treatment of all is changing
-
1:51
management of multiple myeloma in frail/elderly patients
-
1:00
how to treat elderly cll patients in the light of novel therapies
-
3:47
the role of immunotherapy in the aml treatment landscape
-
0:59
the impact of age and comorbidities on the outcomes of patients with cll treated with btk inhibitors
-
1:49
rehabilitation needs of patients with multiple myeloma undergoing car-t therapy